Nevertheless, these results suggest that an alteration in IGF-II receptor levels can influence the expression profiles of a number of transcripts as well as proteins that are involved either directly and/or indirectly in the development of AD pathology. This evidence concerns the gene IGF2R and Alzheimer disease.